Skip to main content

US ClosedU.S. Closed

XBIO: Xenetic Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Xenetic Biosciences, Inc. operates as a biopharmaceutical firm, primarily concentrating on the development of XCART.

52W Range

17thpctl

Volume

0.67×avg

Market Cap

9.12MUSD

P/E Ratio

-3.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Xenetic Biosciences, Inc.

XBIONASDAQ Capital Market·USD·Closed

Xenetic Biosciences, Inc.

XBIONASDAQ·USD·Closed

$3.98

+0.25%

$3.98

+$0.01 (0.25%)

52W Range

17thpctl

Volume

0.67×avg

Mkt Cap

9.12MUSD

P/E

-3.3TTM

Div Yield

–ann